Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Crowne Plaza London - The City

05 jun 2018 8:00 a.m. - 06 jun 2018 3:30 p.m.

19 New Bridge Street, London, EC4V 6DB, United Kingdom

Pharmacovigilance Conference

Session 4: Brexit and the Consequences on Pharmacovigilance Procedures in the EU

Session Chair(s)

Joanna  Harper

Joanna Harper

Expert Inspector, GPvP, Inspectorate, Enforcement and Standards

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

This session will review the current thinking and preparedness for the UK’s exit from the EU. Companies and Regulators have been working to understand and manage the operational implications of Brexit, but what do we know and what is the current thinking on how it will affect pharmacovigilance? In addition to hearing from the speakers, attendees will be encouraged to share their experience.

Speaker(s)

Anabela  Marcal, PharmD

EMA: Timelines Worked Towards 2018 to have Everything Implemented in 2019

Anabela Marcal, PharmD

European Medicines Agency, Netherlands

EMA Liaison Official to the US FDA

Vicki  Edwards, RPh

EFPIA Perspective

Vicki Edwards, RPh

Abbvie, United Kingdom

Vice President, Pharmacovigilance Excellence and International QPPV

Mick  Foy

MHRA Perspective

Mick Foy

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Director of Delivery

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.